BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1590376)

  • 21. Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1259-64. PubMed ID: 7767864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.
    Pulinilkunnil T; An D; Yip P; Chan N; Qi D; Ghosh S; Abrahani A; Rodrigues B
    J Mol Cell Cardiol; 2004 Nov; 37(5):931-8. PubMed ID: 15522270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of taxol on the heparin-induced secretion of lipoprotein lipase from cardiac myocytes.
    Severson DL; Carroll R
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):17-22. PubMed ID: 2571074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts.
    Carroll R; Liu L; Severson DL
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):67-72. PubMed ID: 7646474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac lipoprotein lipase in the spontaneously hypertensive rat.
    Sambandam N; Chen X; Cam MC; Rodrigues B
    Cardiovasc Res; 1997 Feb; 33(2):460-8. PubMed ID: 9074711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
    An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of adipose lipoprotein lipase by thyroid hormone and diabetes. The significance of the low T3 state.
    Gavin LA; McMahon F; Moeller M
    Diabetes; 1985 Dec; 34(12):1266-71. PubMed ID: 3905460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity.
    Severson DL; Carroll R; Kryski A; Ramírez I
    Biochem J; 1987 Nov; 248(1):289-92. PubMed ID: 2829825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sciatic nerve lipoprotein lipase is reduced in streptozotocin-induced diabetes and corrected by insulin.
    Ferreira LD; Huey PU; Pulford BE; Ishii DN; Eckel RH
    Endocrinology; 2002 Apr; 143(4):1213-7. PubMed ID: 11897675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic fate of rat heart endothelial lipoprotein lipase.
    Chajek-Shaul T; Bengtsson-Olivecrona G; Peterson J; Olivecrona T
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E247-54. PubMed ID: 3421325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
    Neitzel AS; Carley AN; Severson DL
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E357-65. PubMed ID: 12397026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid changes in rat heart lipoprotein lipase activity after feeding carbohydrate.
    Pedersen ME; Schotz MC
    J Nutr; 1980 Mar; 110(3):481-7. PubMed ID: 7359219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of clearing factor lipase (lipoprotein lipase) in vivo and from isolated perfused hearts of alloxan diabetic rats.
    Aktin E; Meng HC
    Diabetes; 1972 Mar; 21(3):149-56. PubMed ID: 5011980
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of hormones, amino acids and specific inhibitors on rat heart heparin-releasable lipoprotein lipase and tissue neutral lipase activities during long-term perfusion.
    Stam H; Hülsmann WC
    Biochim Biophys Acta; 1984 Jun; 794(1):72-82. PubMed ID: 6375731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-decasaccharides impair the catabolism of chylomicrons.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone.
    Ewart HS; Carroll R; Severson DL
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):439-42. PubMed ID: 9359413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction.
    Cruz WS; Kwon G; Marshall CA; McDaniel ML; Semenkovich CF
    J Biol Chem; 2001 Apr; 276(15):12162-8. PubMed ID: 11154699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of lipoprotein lipase to calorie intake in streptozotocin-induced diabetic rats.
    Inadera H; Tashiro J; Okubo Y; Ishikawa Y; Shirai K; Saito Y; Yoshida S
    Scand J Clin Lab Invest; 1992 Dec; 52(8):797-802. PubMed ID: 1283230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart.
    Stam H; Hülsmann WC
    Biochem Int; 1983 Aug; 7(2):187-95. PubMed ID: 6679339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites.
    Pulinilkunnil T; Abrahani A; Varghese J; Chan N; Tang I; Ghosh S; Kulpa J; Allard M; Brownsey R; Rodrigues B
    J Mol Cell Cardiol; 2003 Sep; 35(9):1093-103. PubMed ID: 12967632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.